Published in Surgery Litigation and Law Weekly, March 5th, 2010
"As with the Ovion divestiture, this transaction will allow us to focus our resources on addressing unmet needs in our established pelvic health markets while maximizing the return to our shareholders for this non-strategic asset. Importantly, Cooper Surgical is a leader in the in-office gynecology market and thus physicians and patients...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.